Chengdu Kangnuoxing Biopharma
As of the edition of 20 October 2026, Chengdu Kangnuoxing Biopharma runs 1 drug.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 1 |
| Total | 1 |
Where its trials are
- Immune system: 4 trials led
- Ear, nose and throat: 2 trials led
- Lungs and airways: 2 trials led